Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-11

Clinical Trial Update: Metabolic Activation With Almased for Type 2 Diabetes Patients [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase clinical trial evaluating metabolic activation with Almased in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Almased

Snippet

Sponsor: West German Center of Diabetes and Health | Conditions: Type 2 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED